In vivo, lupeol treatment suppresses tumor growth and synergistically cooperates with standard chemotherapy acting on both the PTEN-AKT pathway and the ATP-binding cassette super-family G member 2 (ABCG2) [199]. The gene discussed is PTEN; the disease is neoplasm.